Vaso-occlusive Crisis
Also known as: Vasooclusive Crises / Vasooclusive Crisis / Vaso Occlusive Crisis / Vaso-Occlusive Crises / Hb-SS disease with crisis, unspecified / Hb-SS disease with crisis / Sickle cell anaemia with crisis / Sickle cell anemia with crisis / HB-S disease with mention of crisis / Sickle cell crisis
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB15271 | Crizanlizumab | A monoclonal antibody that targets selectin to reduce the frequency of vasooclusive crises in patients with sickle cell disease. |
| DB01005 | Hydroxyurea | An antimetabolite used to treat sickle cell anemia crisis, resistant chronic myeloid leukemia, and Locally advanced squamous cell carcinomas of the head and neck (excluding the lip). |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB16798 | Cevaretigene ritoparvovec | 2 | Completed | 1 |
| DB06779 | Dalteparin | 2 | Completed | 1 |
| DB01221 | Ketamine | 2 | Completed | 1 |
| DB06690 | Nitrous oxide | 2 | Terminated | 1 |
| DB12544 | Rivipansel | 2 | Completed | 1 |
| DB05737 | Varespladib methyl | 2 | Terminated | 1 |
| DB00158 | Folic acid | 2 / 3 | Completed | 1 |
| DB00295 | Morphine | 2 / 3 | Completed | 1 |
| DB11133 | Omega-3 fatty acids | 2 / 3 | Completed | 1 |
| DB00641 | Simvastatin | 2 / 3 | Completed | 1 |
| DB03904 | Urea | 2 / 3 | Completed | 1 |
| DB09322 | Zinc sulfate | 2 / 3 | Completed | 1 |
| DB06605 | Apixaban | 3 | Terminated | 1 |
| DB12246 | Inclacumab | 3 | Active Not Recruiting | 1 |
| DB12246 | Inclacumab | 3 | Recruiting | 1 |
| DB12246 | Inclacumab | 3 | Terminated | 1 |
| DB01221 | Ketamine | 3 | Recruiting | 2 |
| DB00295 | Morphine | 3 | Not Yet Recruiting | 1 |
| DB11333 | Poloxamer 188 | 3 | Completed | 1 |
| DB12544 | Rivipansel | 3 | Terminated | 1 |
| DB12778 | Rivipansel | 3 | Terminated | 1 |
| DB00708 | Sufentanil | 3 | Not Yet Recruiting | 1 |
| DB11300 | Thrombin | Not Available | Recruiting | 1 |